home / stock / coll / coll quote
Last: | $35.48 |
---|---|
Change Percent: | 0.31% |
Open: | $35.83 |
Close: | $35.48 |
High: | $36.02 |
Low: | $35.33 |
Volume: | 193,397 |
Last Trade Date Time: | 04/24/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$35.48 | $35.83 | $35.48 | $36.02 | $35.33 | 193,397 | 04-24-2024 |
$35.94 | $35 | $35.94 | $36.5054 | $34.9226 | 559,415 | 04-23-2024 |
$34.74 | $34.93 | $34.74 | $35.31 | $34.55 | 414,728 | 04-22-2024 |
$34.84 | $34.65 | $34.84 | $35.34 | $34.24 | 325,386 | 04-19-2024 |
$34.77 | $35.47 | $34.77 | $35.47 | $34.69 | 203,939 | 04-18-2024 |
$35.45 | $35.47 | $35.45 | $35.75 | $34.76 | 256,530 | 04-17-2024 |
$35.4 | $35.03 | $35.4 | $35.81 | $34.7415 | 323,773 | 04-16-2024 |
$35.14 | $35.67 | $35.14 | $35.98 | $35.12 | 366,303 | 04-15-2024 |
$35.71 | $36.51 | $35.71 | $36.51 | $35.47 | 380,384 | 04-12-2024 |
$36.39 | $37.97 | $36.39 | $37.97 | $35.72 | 462,878 | 04-11-2024 |
$37.99 | $38.29 | $37.99 | $38.89 | $37.95 | 311,415 | 04-10-2024 |
$38.79 | $39.37 | $38.79 | $39.53 | $38.41 | 204,277 | 04-09-2024 |
$39.42 | $39.67 | $39.42 | $40.024 | $38.8858 | 235,217 | 04-08-2024 |
$39.99 | $39.23 | $39.99 | $40.26 | $39.05 | 384,718 | 04-05-2024 |
$39.3 | $39.6 | $39.3 | $40.49 | $39.175 | 366,245 | 04-04-2024 |
$39.45 | $38.25 | $39.45 | $39.46 | $38.24 | 261,635 | 04-03-2024 |
$38.4 | $38.35 | $38.4 | $39.0299 | $38.12 | 335,646 | 04-02-2024 |
$38.88 | $38.54 | $38.88 | $38.97 | $37.625 | 351,385 | 04-01-2024 |
$38.82 | $40.87 | $38.82 | $40.95 | $38.59 | 613,299 | 03-29-2024 |
$38.82 | $40.87 | $38.82 | $40.95 | $38.59 | 613,299 | 03-28-2024 |
News, Short Squeeze, Breakout and More Instantly...
Collegium Pharmaceutical Inc. Company Name:
COLL Stock Symbol:
NASDAQ Market:
Collegium Pharmaceutical Inc. Website:
STOUGHTON, Mass., April 25, 2024 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a leading, diversified specialty pharmaceutical company committed to improving the lives of people living with serious medical conditions, today announced that it will report first quarter 2024...
STOUGHTON, Mass., April 11, 2024 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL) (the “Company”), a leading, diversified specialty pharmaceutical company committed to improving the lives of people living with serious medical conditions, today announced that it has ...
STOUGHTON, Mass., April 03, 2024 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a leading, diversified specialty pharmaceutical company committed to improving the lives of people living with serious medical conditions, today announced that management will participate in a ...